According to a comprehensive review published in Genes & Diseases by Yining Wang and colleagues, T cell exhaustion plays a complex and dual role in organ transplantation, acting both as a mechanism to promote graft tolerance and as a source of vulnerability to infections and malignancies. The dysfunctional immune state develops during prolonged antigen exposure, … Read more
Antimicrobial Peptide Research Reveals Unexpected Bacterial Rigidity Research led by Cornell College faculty and students indicates that the antimicrobial peptide Magainin 2 induces unexpected biomechanical changes in Escherichia coli when administered at high concentrations. Contrary to previous assumptions that peptides soften bacterial cell walls, the study found that high doses cause E. coli to become … Read more
Researchers are accelerating the development of a recombinant vesicular stomatitis virus (rVSV) vaccine candidate targeting the Bundibugyo ebolavirus, a strain previously overlooked by pharmaceutical firms due to limited profit potential. According to Thomas Geisbert, a professor at the University of Texas Medical Branch, the candidate is currently being prepared for production by the International AIDS … Read more
The Korea Research Institute of Chemical Technology (KRICT) has launched the DEL CoreBank Platform, a public drug discovery service that uses DNA-Encoded Library (DEL) technology to screen tens of millions of compounds simultaneously. This platform provides domestic researchers with a faster, more cost-effective alternative to expensive overseas outsourcing, aiming to accelerate the discovery of drugs … Read more
The Future of Non-Invasive Diagnostics: Can a Spit Test Save Millions? For decades, the gold standard for detecting esophageal cancer has been the endoscopy—a procedure that, while effective, is invasive, expensive, and often inaccessible to those living in rural or underserved regions. By the time a patient feels the physical struggle of swallowing, the window … Read more
Beyond the Synapse: The New Era of Cellular Neuroscience For decades, the study of the brain focused largely on the “wiring”—how neurons connect and transmit signals. But a paradigm shift is occurring. We are moving deeper, shifting our gaze from the network to the machinery inside the cell. The frontier of neuroscience is no longer … Read more
The Bio-Security Revolution: Protecting Tomorrow’s Trillion-Dollar Biotech Industry The biotechnology industry is facing a growing threat: the theft and misuse of valuable engineered cell lines. Recent reports from the Centers for Disease Control and Prevention (CDC) and the Department of Homeland Security (DHS) indicate a surge in unauthorized shipments of biological materials, alongside intelligence suggesting … Read more
The Future of Drug Testing: Could “Organ Sacks” Replace Animals in Labs? The landscape of biomedical research is undergoing a dramatic shift. Driven by ethical concerns and practical limitations, the traditional reliance on animal testing is waning. Now, a Bay Area biotech startup, R3 Bio, is proposing a radical alternative: nonsentient “organ sacks” – essentially, … Read more
Biotech Pivot, Nasdaq Compliance March 23, 2026 Conduit Pharmaceuticals’ ambitious shift from real estate to biotech is facing headwinds, with a low market cap and Nasdaq listing concerns prompting a reverse stock split. Conduit Pharmaceuticals Faces Critical Juncture After Pivot to Biotech The transformation from a special purpose acquisition company (SPAC) focused on real estate … Read more
FDA Under Scrutiny: A Potential Shift in Rare Disease Drug Approvals Senator Ron Johnson (R-Wis.) has launched an investigation into the Food and Drug Administration’s (FDA) rejections of treatments for rare diseases, signaling growing concern over the agency’s decision-making process. The senator is specifically requesting access to the complete response letters – official rejections – … Read more